Independent, impersonal educational research. Not investment, medical, tax or legal advice. Full disclosures: https://everlifecapital.beehiiv.com/p/full-disclosure-and-terms-of-research
Discover cutting-edge companies taking aim at the causes of aging.
Money can buy better care and more choices. It cannot currently buy healthy life far beyond roughly 80 to 100 years. Longevity biotech companies are trying to change that.
You may want more healthy years for yourself and the people you love. You may also want to recognize an important company before its progress is obvious to everyone else.
The difficulty is that early-stage longevity biotech can feel like a casino. The science is complex, private valuations are often hidden and impressive laboratory results frequently fail in people.
EverLife does the research so you can understand which companies may deserve deeper attention, what remains unproved and what result matters next.
What EverLife gives you
• What each company is trying to accomplish, in plain English
• Human evidence separated from animal and laboratory findings
• Publicly supportable valuation and financing information
• The risks, missing information and next milestone
• Dated 25-Gate scores and changes over time
• Watchlist, Scout and Tracker classifications with the reason for each decision
The benefit is not education for its own sake. It is saving research time, avoiding expensive hype and developing the judgment to recognize meaningful progress earlier.
Why I built it
I spent more than 25 years building companies and sold most of them in 2026. I have evaluated real company pitches, invested my own money and lost money.
That experience taught me that an exciting story is not enough. I built EverLife's 25-Gate Framework to separate scientific potential, evidence, execution, valuation and risk.
I now teach that process while continuing to evaluate companies I may invest in myself. Relevant interests are disclosed.
A living research record
Each company starts with a dated baseline: first review date, current score, publicly supportable valuation, evidence level, classification and next milestone.
Future updates show what changed, whether the score or valuation moved and why a company advanced, stayed in place or was downgraded.
Tracker, Scout and Watchlist are research classifications. They are not recommendations or buy lists.
Start here
Subscribe to the free newsletter to discover the companies and ideas. Premium members receive the complete rankings, 25-Gate scorebooks, valuation tracking and continuing company updates.
Start with the Longevity Biotech Research Tracker: https://everlifecapital.beehiiv.com/p/longevity-biotech-research-tracker-companies-i-m-studying-as-the-field-develops
EverLife publishes independent, impersonal educational research. It does not provide personalized advice, transaction access or a promise of returns.